Meeting Report
miPSMA Index: Comprehensive and Automated Quantification of 18F-DCFPyL (PyL-PSMA) PET/CT for Prostate Cancer Staging
Kerstin Johnsson, Hannicka Sahlstedt, Johan Brynolfsson, Johnny Dang, John Ceccoli, Tess Lin, Jens Richter, Karl Sjostrand, Lars Edenbrandt, Matthias Eiber and Aseem Anand
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1435;
Kerstin Johnsson
1Exini Diagnostics AB Lund Sweden
Hannicka Sahlstedt
1Exini Diagnostics AB Lund Sweden
Johan Brynolfsson
1Exini Diagnostics AB Lund Sweden
Johnny Dang
1Exini Diagnostics AB Lund Sweden
John Ceccoli
2Progenics Pharmaceuticals Inc New York NY United States
3Progenics Pharmaceuticals Inc New York NY United States
Tess Lin
2Progenics Pharmaceuticals Inc New York NY United States
3Progenics Pharmaceuticals Inc New York NY United States
Jens Richter
1Exini Diagnostics AB Lund Sweden
Karl Sjostrand
2Progenics Pharmaceuticals Inc New York NY United States
3Progenics Pharmaceuticals Inc New York NY United States
Lars Edenbrandt
1Exini Diagnostics AB Lund Sweden
Matthias Eiber
4Klinikum rechts der Isar Munich Germany
Aseem Anand
1Exini Diagnostics AB Lund Sweden
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
miPSMA Index: Comprehensive and Automated Quantification of 18F-DCFPyL (PyL-PSMA) PET/CT for Prostate Cancer Staging
Kerstin Johnsson, Hannicka Sahlstedt, Johan Brynolfsson, Johnny Dang, John Ceccoli, Tess Lin, Jens Richter, Karl Sjostrand, Lars Edenbrandt, Matthias Eiber, Aseem Anand
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1435;
miPSMA Index: Comprehensive and Automated Quantification of 18F-DCFPyL (PyL-PSMA) PET/CT for Prostate Cancer Staging
Kerstin Johnsson, Hannicka Sahlstedt, Johan Brynolfsson, Johnny Dang, John Ceccoli, Tess Lin, Jens Richter, Karl Sjostrand, Lars Edenbrandt, Matthias Eiber, Aseem Anand
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1435;
Jump to section
Related Articles
- No related articles found.